Author pages are created from data sourced from our academic publisher partnerships and public sources.
Criteria for the diagnosis of corticobasal degeneration
Current criteria for the clinical diagnosis of pathologically confirmed corticobasal degeneration (CBD) no longer reflect the expanding understanding of this disease and its clinicopathologic… Expand
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
BACKGROUND Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression. OBJECTIVE To determine whether a range of dosages of… Expand
The clinically important difference on the unified Parkinson's disease rating scale.
- L. Shulman, A. Gruber-Baldini, K. Anderson, P. Fishman, S. Reich, W. Weiner
- Psychology, Medicine
- Archives of neurology
OBJECTIVE To determine the estimates of minimal, moderate, and large clinically important differences (CIDs) for the Unified Parkinson's Disease Rating Scale (UPDRS). DESIGN Cross-sectional… Expand
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.
OBJECTIVE To compare the efficacy of treadmill exercises and stretching and resistance exercises in improving gait speed, strength, and fitness for patients with Parkinson disease. DESIGN A… Expand
Natural history of multiple system atrophy in the USA
The use of alternative therapies by patients with Parkinson’s disease
Objective: To determine the prevalence and spectrum of use of alternative therapy (AT) by patients with PD and to determine whether use of AT correlates with demographic, social, or disease-specific… Expand
Causative factors and epidemiology of bilateral vestibulopathy in 255 patients
In their study of bilateral vestibulopathy, Zingler and colleagues employed standard bedside tests to screen for hearing loss: asking patients whether they had impaired hearing and whispered speech.… Expand
The evolution of disability in Parkinson disease
- L. Shulman, A. Gruber-Baldini, +4 authors W. Weiner
- Movement disorders : official journal of the…
- 30 April 2008
The objectives of this study are to assess the level of disease severity associated with disability in Parkinson disease (PD) and the sequence of loss of independence in basic and instrumental… Expand
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.
BACKGROUND Mutations in the tau gene have been reported in families with frontotemporal dementia (FTD) linked to chromosome 17. It remains uncertain how commonly such mutations are found in patients… Expand
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
- I. Leroi, J. Brandt, +4 authors L. Marsh
- Psychology, Medicine
- International journal of geriatric psychiatry
- 1 January 2004
To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD).